Mark E Peterson
Overview
Explore the profile of Mark E Peterson including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
63
Citations
523
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Alexander D, Cobucci G, da Motta C, Cid G, Belizzi L, de Jesus A, et al.
J Vet Intern Med
. 2025 Mar;
39(2):e70045.
PMID: 40072270
A 9-year-old mixed breed cat with a history of recurrent ulcerated skin lesions was diagnosed with nocardiosis. Three months after initiating potentiated sulfonamide treatment, the cat developed goitrous hypothyroidism, characterized...
2.
Peterson M, Carmody S, Rishniw M
J Am Vet Med Assoc
. 2024 Dec;
:1-6.
PMID: 39724773
Objective: Many hyperthyroid cats (15% to 50%) have concurrent chronic kidney disease (CKD) that is "masked" and will not become azotemic until after treatment. Previous studies reported that mild-to-moderate azotemic...
3.
Bechtold M, Lin Y, Miller M, Prieto J, Frederick C, Bennett L, et al.
PLoS One
. 2024 Jun;
19(6):e0305271.
PMID: 38857299
Hyperthyroidism is the most common feline endocrinopathy. In hyperthyroid humans, untargeted metabolomic analysis identified persistent metabolic derangements despite achieving a euthyroid state. Therefore, we sought to define the metabolome of...
4.
Stammeleer L, Xifra P, Serrano S, Rishniw M, Daminet S, Peterson M
J Vet Intern Med
. 2024 Mar;
38(3):1359-1369.
PMID: 38440934
Background: Hyperthyroid cats commonly have systemic hypertension, with a reported prevalence of 7% to 48%. Although hypertension might be expected to resolve once treatment restores euthyroidism, it can persist or...
5.
Peterson M, Dougherty E, Rishniw M
Am J Vet Res
. 2024 Feb;
85(5).
PMID: 38382201
Objective: Clinicians commonly use thyroid-stimulating hormone (TSH) concentrations to diagnose thyroid disorders in humans and dogs. In cats, canine TSH chemiluminescent immunoassays (CLIA) assays are commonly used to measure TSH,...
6.
Peterson M, Rishniw M
J Vet Intern Med
. 2023 Sep;
37(6):2039-2051.
PMID: 37668163
Background: Hyperthyroid cats often have urine specific gravity (USG) values <1.035. It remains unclear how USG changes after treatment, if USG can be used to predict azotemia after treatment, or...
7.
Prieto J, Carney P, Smith S, Miller M, Rishniw M, Randolph J, et al.
Vet Clin Pathol
. 2023 Aug;
52(3):493-502.
PMID: 37528445
Background: Cats commonly develop thyroid disease but little is known about the long-term biological variability of serum thyroid hormone and thyrotropin (thyroid-stimulating hormone; TSH) concentrations. Objectives: We aimed to determine...
8.
Smith S, Carney P, Prieto J, Miller M, Randolph J, Farace G, et al.
Vet Clin Pathol
. 2022 Oct;
52(1):44-52.
PMID: 36289013
Background: Biological variation helps determine whether population-based or subject-based reference intervals are more appropriate to assess changes in serial analytical values. Previous studies have investigated the biological variation of biochemical...
9.
Xifra P, Serrano S, Peterson M
J Vet Intern Med
. 2022 Oct;
36(6):1931-1941.
PMID: 36200596
Background: Approximately 75% of hyperthyroid cats lose muscle mass as accessed with a muscle condition scoring (MCS) system. After treatment, MCS improves as the cats regain muscle mass. Objectives: To...
10.
Van Poucke M, Van Renterghem E, Peterson M, van den Berg M, Stock E, Peelman L, et al.
J Vet Intern Med
. 2022 Sep;
36(5):1597-1606.
PMID: 36054182
Background: Primary congenital hypothyroidism (CH) is a rare endocrine disorder in cats with a largely unknown genetic cause. Objectives: Describe the clinical presentation of CH in 11 affected cats and...